Related Experiment Video
Updated: Oct 3, 2026

Improved Rodent Model of Myocardial Ischemia and Reperfusion Injury
Published on: March 7, 2022
Cardioprotective effects of transforming growth factor-beta1 during early reoxygenation or reperfusion are mediated
G F Baxter1, M M Mocanu, B K Brar
1The Hatter Institute, University College, Grafton Way, London WC1E 6DB, U.K. hatter-institute@ucl.ac.uk
Abstract:
Apoptosis contributes to myocardial cell death during ischemia and reperfusion, especially during reperfusion. Growth factor "survival" signaling attenuates apoptosis. We therefore examined the effects of transforming growth factor-beta1 (TGF-beta1) on reperfusion injury and assessed the role of p42/p44 MAPK signaling in TGF-beta1-induced protection. Rat ventricular myocytes were subjected to hypoxia and reoxygenation. TGF-beta1 (0.2 ng/ml) was applied to cells during reoxygenation and the extent of apoptosis was determined by TUNEL and annexin V binding assays. Further studies were conducted in intact rat hearts subjected to regional ischemia and reperfusion. TGF-beta1 (0.2 ng/ml) was perfused during early reperfusion. In cells, incubation with TGF-beta1 (0.2 ng/ml) during reoxygenation attenuated the extent of cell membrane damage (trypan blue uptake) and also reduced the numbers of TUNEL-and annexin V-positive cells. Reduction of apoptosis was abrogated by PD98059 (5 microM), an inhibitor of p42/p44 MAPK activation. TGF-beta1 activated p42/p44 MAPK transiently in normoxic myocytes. When intact hearts received TGF-beta1 (0.2 ng/ml) during early reperfusion, infarct size was reduced from 39.4 +/- 3.1% to 17.3 +/- 3.1% (p < 0.01). This protective action of TGF-beta1 was abrogated by PD98059. These studies are the first to show that TGF-beta attenuates cardiac myocyte apoptosis during early reperfusion and limits infarct size through p42/p44 MAPK activation.
Insights
Transforming growth factor-beta1 (TGF-beta1) reduces heart cell death during reperfusion injury. This protection against apoptosis and infarct size is mediated by p42/p44 mitogen-activated protein kinase (MAPK) signaling.
Area of Science:
- Cardiovascular Biology
- Cellular Signaling
- Molecular Medicine
Background:
- Myocardial ischemia-reperfusion injury involves significant apoptosis, or programmed cell death.
- Growth factors can promote cell survival and counteract apoptosis.
- Transforming growth factor-beta1 (TGF-beta1) is a key growth factor implicated in cellular responses.
Purpose of the Study:
- To investigate the protective effects of TGF-beta1 against reperfusion-induced apoptosis in cardiac myocytes.
- To determine the role of p42/p44 mitogen-activated protein kinase (MAPK) signaling in TGF-beta1's protective mechanism.
Main Methods:
- Rat ventricular myocytes were subjected to hypoxia and reoxygenation.
- Apoptosis was quantified using TUNEL and annexin V assays.
- Intact rat hearts underwent regional ischemia and reperfusion, with TGF-beta1 administration during reperfusion.
- The p42/p44 MAPK pathway was inhibited using PD98059.
Main Results:
- TGF-beta1 significantly attenuated cell membrane damage and reduced apoptosis in myocytes during reoxygenation.
- The anti-apoptotic effect of TGF-beta1 was blocked by the p42/p44 MAPK inhibitor PD98059.
- In intact hearts, TGF-beta1 administration during reperfusion markedly reduced infarct size.
- The infarct-limiting effect of TGF-beta1 was abolished by PD98059, indicating MAPK pathway involvement.
Conclusions:
- TGF-beta1 effectively mitigates cardiac myocyte apoptosis during early reperfusion.
- TGF-beta1 limits infarct size in a model of myocardial ischemia-reperfusion injury.
- The protective mechanisms of TGF-beta1 against cardiac reperfusion injury are dependent on the activation of the p42/p44 MAPK signaling pathway.
Related Concept Videos
MAPK Signaling Cascades
Regulation of Angiogenesis and Blood Supply
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
TGF - β Signaling Pathway